Internal Medicine, Gastroenterology · Allentown, PA
NPI
1194759852
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1501 N Cedar Crest Blvd, Suite 110
Allentown, PA, 18104
Phone (610) 821-2828
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
3,225 services
Medicare patients, 2024
577
Average age 74
Drug cost, 2024
$2.7M
1,396 prescriptions
Company payments, 2025
$204
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paola G Blanco was code 99213 (office e&m - established), 146 times for 121 patients. In total Paola G Blanco billed 3,225 services in 47 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 146 | 121 | $58.16 | $8,492 |
| 43239 Upper GI Endoscopy | Facility | 117 | 115 | $80.69 | $9,440 |
| 99214 Office E&M - Established | Office | 107 | 89 | $89.96 | $9,626 |
| 45385 Colonoscopy - Lesion Removal | Facility | 73 | 73 | $194.18 | $14K |
| 45380 Lower GI Endoscopy - Other | Facility | 66 | 66 | $91.25 | $6,023 |
| 99222 Hospital E&M - Initial | Facility | 63 | 63 | $98.60 | $6,212 |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 48 | $59.45 | $3,151 |
| 99221 Hospital E&M - Initial | Facility | 51 | 51 | $62.35 | $3,180 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 29 | $12.49 | $375 |
| 45378 Lower GI Endoscopy - Other | Facility | 23 | 23 | $129.87 | $2,987 |
| 99204 Office E&M - New | Office | 22 | 22 | $116.86 | $2,571 |
| 43235 Upper GI Endoscopy | Facility | 19 | 19 | $82.39 | $1,565 |
| 99212 Office E&M - Established | Office | 18 | 18 | $22.62 | $407 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 17 | 16 | $154.31 | $2,623 |
| 99203 Office E&M - New | Office | 14 | 14 | $71.78 | $1,005 |
By year: 2022 $216K for 8,053 services; 2023 $172K for 5,919 services; 2024 $118K for 3,225 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paola G Blanco prescribed most often to Medicare patients was Pantoprazole Sodium, with 324 prescriptions and refills. In total Paola G Blanco wrote 1,396 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 324 | 691 | 94 | $4,337 |
| Omeprazole Generic | 194 | 494 | 64 | $2,340 |
| Famotidine Generic | 90 | 224 | 32 | $1,245 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 54 | 54 | 50 | $912 |
| Stelara Ustekinumab | 52 | 71 | Under 11 | $1.5M |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 51 | 51 | 51 | $3,431 |
| Dicyclomine Hcl Generic | 50 | 71 | 17 | $955 |
| Cholestyramine Cholestyramine (With Sugar) | 49 | 70 | 22 | $3,181 |
| Skyrizi On-Body Risankizumab-Rzaa | 47 | 57 | Under 11 | $1.0M |
| Sucralfate Generic | 42 | 46 | 13 | $9,380 |
| Linzess Linaclotide | 35 | 49 | Under 11 | $24K |
| Dexlansoprazole Dr Dexlansoprazole | 32 | 48 | Under 11 | $8,847 |
| Colestipol Hcl Generic | 30 | 76 | Under 11 | $6,931 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 25 | 25 | 23 | $369 |
| Esomeprazole Magnesium Generic | 24 | 70 | Under 11 | $509 |
Brand drugs: - claims; generic drugs: 1,134 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paola G Blanco $204 ($204 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.